Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.83 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.83 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.83 |
| ▸ | MEN1 | O00255 | 2/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.83 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.83 |
| ▸ | TP53 | P04637 | 1/20 | 0.83 |
| ▸ | HPGD | P15428 | 1/20 | 0.83 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.83 |
| ▸ | TUBB4A | P04350 | 7/20 | 0.57 |
| ▸ | TUBB | P07437 | 7/20 | 0.57 |
| ▸ | TUBA3C | P0DPH7 | 7/20 | 0.57 |
| ▸ | TUBA1B | P68363 | 7/20 | 0.57 |
| ▸ | TUBA4A | P68366 | 7/20 | 0.57 |
| ▸ | TUBB4B | P68371 | 7/20 | 0.57 |
| ▸ | TUBB3 | Q13509 | 7/20 | 0.57 |
| ▸ | TUBB2A | Q13885 | 7/20 | 0.57 |
| ▸ | TUBB8 | Q3ZCM7 | 7/20 | 0.57 |
| ▸ | TUBA3E | Q6PEY2 | 7/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7258031 | 0.91 | LMNA (0.69) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| Albendazole SCHEMBL31704207 | 0.91 | LMNA (1.00) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| Albendazole SCHEMBL247151 | 0.91 | LMNA (1.00) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| SCHEMBL18142126 | 0.88 | LMNA (0.78) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| Albendazole SCHEMBL29612190 | 0.88 | LMNA (0.85) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| SCHEMBL11809370 | 0.87 | LMNA (0.63) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| Albendazole SCHEMBL5502364 | 0.87 | LMNA (0.91) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| SCHEMBL24209752 | 0.83 | LMNA (0.79) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| SCHEMBL23867539 | 0.82 | LMNA (0.65) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 | |
| Albendazole SCHEMBL28325579 | 0.82 | LMNA (0.72) | LMNACYP1A2MAPK1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220017471-A1 | FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS | UNIV SHANGHAI TECHNOLOGY (CN) | 2022-01-20 | — | — | US | disclosed |
| WO-2003011859-A2 | OXAZOLIDINONE DERIVATIVES AS ANTIBACTERIAL AGENTS | CIPLA LTD. (IN) | 2003-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017471-A1 | FUNCTIONALITY INDEPENDENT LABELING OF ORGANIC COMPOUNDS | PAICS, PFAS, OTC | LMNA 1245/4885CYP1A2 339/4885MAPK1 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.